Sanofi Pasteur and Actor Chris O'Donnell Launch Fluzone® Intradermal (Influenza Virus Vaccine) VacciNation Tour to Raise Awareness About Importance of Annual Flu Shot and Vaccine Options for Adults
Recent survey findings indicate majority of adults fear spreading the flu to family and friends, yet only a third of adults 18 through 64 years of age get a flu shot
-- Actor Chris O'Donnell teams up with Sanofi Pasteur to educate adults 18 through 64 years of age about the seriousness of influenza and vaccine options available, including Fluzone® Intradermal vaccine
-- Fluzone Intradermal vaccine is an alternative immunization option for adults (18 through 64 years of age) and features an ultra-thin needle that is 90 percent smaller
Sep 12, 2012
SWIFTWATER, Pa., Sept. 12, 2012 /PRNewswire/ -- Sanofi Pasteur and Actor Chris O'Donnell are teaming up to raise awareness about the seriousness of influenza and available vaccine options for adults 18 through 64 years of age, including Fluzone® Intradermal vaccine.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/57037-sanofi-pasteur-chris-o-donnell-fluzone-intradermal-influenza-virus-vaccine
"I understand the importance of helping to protect myself against the flu, which is why I got my flu vaccination," said O'Donnell. "When my doctor and I talked this year about what may make my experience a good one, we determined Fluzone Intradermal vaccine was the best choice for me. The device has a needle smaller than a grain of rice, which for me, made a big difference."
Despite a recommendation by the Centers for Disease Control and Prevention (CDC) that everyone six months of age and older receive an annual influenza vaccination, on average, only a third of adults in the U.S. 18 through 64 years of age are immunized, leaving far too many unprotected and at risk for spreading the virus to those at high-risk like young children and older adults.
Results from a recent telephone survey of 663 adults revealed these low rates highlight a disconnect between fear and action, as two out of every three (67 percent) adults 18 through 64 years of age said their biggest fear regarding influenza is spreading the virus to their loved ones, yet three in five (61 percent) adults said they remain unvaccinated against the flu.
The survey also showed that 53 percent of adults 18 through 64 years of age who were vaccinated annually reported that their vaccination experience would be better if the needle was much smaller, and 65 percent said their experience would be better if access to the flu shot was more convenient.
These low immunization rates prompted star of the hit television series "NCIS Los Angeles," Chris O'Donnell, to join Sanofi Pasteur in a nationwide effort to educate adults, a sometimes overlooked population, about available vaccine options and encourage influenza immunization.
"It is important for people to remember influenza can strike anyone and that the single most important thing adults can do to help prevent getting or spreading the flu is to get their annual flu vaccination," said Carlos E. Picone, M.D., F.C.C.P., Vice-Chair of the Department of Internal Medicine at Sibley Memorial Hospital in Washington, D.C. "I encourage adults to speak with their health care provider or pharmacist to determine if vaccination is right for them and to learn more about available vaccine options."
Fluzone Intradermal vaccine is the only FDA-approved intradermal flu vaccine for adults 18 through 64 years of age in the United States. The device features an ultra-thin, 90 percent smaller needle that works just under the skin to help provide adults with the flu protection they need.
To find out where Fluzone Intradermal vaccine is available in your area, visit www.Fluzone.com or talk to your health care provider or pharmacist for more information.
About Fluzone Intradermal Coop de Quill VacciNation Tour
Additionally, the Coop de Quill VacciNation Tour is joining forces with various retail pharmacy partners to bring Fluzone Intradermal vaccine to cities across the nation. The Coop de Quill vehicle will be making a stop in five tour cities: Baltimore, Chicago, Raleigh, San Francisco, and Seattle. At each stop attendees will have the opportunity to have one-on-one discussions with clinic pharmacists to better understand the importance of annual influenza vaccination and the various vaccine options available to them. Attendees can also get immunized with Fluzone Intradermal vaccine at a flu clinic hosted at each retailer and receive other items to help keep them healthy this flu season.
To help protect more adults from influenza, Sanofi Pasteur has donated influenza vaccine to AmeriCares as part of the campaign. AmeriCares is a nonprofit humanitarian aid organization that works to address health care gaps globally, both in times of emergency response or as part of ongoing support for sustainable health care. For more information about AmeriCares, visit www.americares.org.
About Fluzone Intradermal Vaccine
For more information about Fluzone Intradermal vaccine, talk to your health care professional and see complete Patient Information.
About The Survey
This survey was sponsored by Sanofi Pasteur, the vaccines division of Sanofi.
Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us
Forward Looking Statements
SOURCE Sanofi Pasteur